Imatinib Completed Phase 4 Trials for Chronic Myeloid Leukemia (CML)

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT00845221Glivec in Pediatric Chronic Myeloid Leukemia (CML)